The Australian Global Health Alliance is delighted to announce Melbourne Children’s Global Health as the newest Bronze Sponsor of the Alliance. Melbourne Children’s Global Health (MCGH) is an initiative of Melbourne Children’s Campus- a partnership of Murdoch Children’s Research Institute; The University of Melbourne, Department of Paediatrics; and The Royal Children’s Hospital, Melbourne. MCGH aims […]
Thursday, December 2, 2021 Australia’s leading epidemiologists, global health, business, development and aid organisations have united to call on the Federal Government to urgently ramp up its global vaccination efforts following the emergence of the Omicron variant. The coalition, brought together by End COVID For All, includes the Business Council of Australia, the Australian Global […]
Dear Prime Minister, We write to you out of our grave concern regarding the state of global vaccine inequity, and the opportunity we believe Australia has to help address this vital issue affecting us all….DOWNLOAD PDF OF LETTER
Thursday, December 2, 2021 Australia’s leading epidemiologists, global health, business, development and aid organisations have united to call on the Federal Government to urgently ramp up its global vaccination efforts following the emergence of the Omicron variant. The coalition, brought together by End COVID For All, includes the Business Council of Australia, the Australian Global […]
GENEVA – The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria today unanimously approved a new response mechanism to support countries to respond to COVID-19 and mitigate the impact on programs to fight HIV, TB, malaria and systems for health, effectively doubling the amount of available funding to up to US$1 billion. The […]
9 November 2021: The Australian Global Health Alliance is pleased to announce Medicines for Malaria Venture (MMV) as a new Bronze Sponsor. Medicines for Malaria Venture (MMV) is a leading product development partnership (PDP) in the field of antimalarial drug research and development. Its mission is to reduce the burden of malaria in disease-endemic countries by […]
The Australian Government is being urged to commit to further action to fight the COVID-19 pandemic in poor countries before the virus mutates and renders current vaccines ineffective. A new report, A Shot of Hope – Australia’s role in vaccinating the World, which the Australian Global Health Alliance co-authored, notes that two-thirds of 77 epidemiologists surveyed […]
06 October 2021 WHO recommendation for wider use of the RTS,S malaria vaccine is largely based on data gathered during malaria vaccine pilots which took place in Kenya, Ghana and Malawi Gavi, the Vaccine Alliance, the Global Fund to Fight AIDS, Tuberculosis and Malaria and global health agency Unitaid have together committed nearly US$ 70 […]
06 October 2021 WHO recommendation for wider use of the RTS,S malaria vaccine is largely based on data gathered during malaria vaccine pilots which took place in Kenya, Ghana and Malawi Gavi, the Vaccine Alliance, the Global Fund to Fight AIDS, Tuberculosis and Malaria and global health agency Unitaid have together committed nearly US$ 70 […]
A REGIONAL COVID RESPONSE NEEDS MORE FROM AUSTRALIA Media Release | 23 September 2021 Pacific Friends of Global Health welcomes the news that the Australian Government has pledged an additional 40 million COVID-19 vaccines for the Indo-Pacific region. Australia has now promised a total of 60 million vaccines by the end of 2022. The announcement […]
GENEVA – The COVID-19 pandemic had a devastating impact on the fight against HIV, TB and malaria in 2020, according to a new report released by the Global Fund today. The Results Report shows that while some progress was made, key programmatic results have declined for the first time in the history of the Global Fund. “To mark […]
Unitaid has invested more than US$ 45 million into hepatitis C since 2015, driving the development of better and more affordable tools and demonstrating that it is possible to reach – and cure – people in resource-limited settings. “We set out to improve hepatitis C care through a complementary set of investments. Over the past […]
Unitaid and the Clinton Health Access Initiative, Inc. (CHAI) announce pricing agreement with pharmaceutical company Hetero Labs LTD to make available generic version of best-in-class second-line therapy for people living with HIV Geneva, 26 July 2021 – Unitaid and CHAI today announced a groundbreaking pricing agreement with pharmaceutical company Hetero Labs LTD to make darunavir boosted […]
New mechanism builds on Gavi COVAX Advance Market Commitment (AMC) cost-sharing arrangement Washington DC / Geneva, 26 July 2021 – COVAX and the World Bank will accelerate COVID-19 vaccine supply for developing countries through a new financing mechanism that builds on Gavi’s newly designed AMC cost-sharing arrangement. This allows AMC countries to purchase doses beyond the […]
